Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Maurel

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|March 1, 2008
Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcomaCarlos Conill, Xavier Setoain, Luis Colomo, et al.
Anti-Cancer Drugs|February 6, 2003
Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancerAngel Artal-Cortés, Javier Martínez-Trufero, Ana Herrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancerCristina Nadal, Joan Maurel, Rosa Gallego, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinomaJoan Maurel, Andrés Cervantes, Carlos Conill, et al.
Future Oncology (London, England)|July 14, 2017
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastasesEnrique Aranda, Jorge Aparicio, José Ignacio Bilbao, et al.
ESMO Open|October 13, 2017
Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patientsAnastassia Negrouk, Denis Lacombe, Fatima Cardoso, et al.
Seminars in Cancer Biology|September 26, 2025
Lipid-laden macrophages in atherosclerosis and cancerM C Martinez-Campanario, Marlies Cortés, Lu Han, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 3, 2023
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)Ana Fernández Montes, Vicente Alonso, Enrique Aranda, et al.
Molecular Carcinogenesis|February 4, 2015
LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-METBelén Mezquita, Estela Pineda, Jovita Mezquita, et al.
Journal of Pain and Symptom Management|August 30, 2008
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancerS Gail Eckhardt, Peter De Porre, David Smith, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Journal of Magnetic Resonance Imaging : JMRI|March 1, 2008
Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcomaCarlos Conill, Xavier Setoain, Luis Colomo, et al.
Anti-Cancer Drugs|February 6, 2003
Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancerAngel Artal-Cortés, Javier Martínez-Trufero, Ana Herrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancerCristina Nadal, Joan Maurel, Rosa Gallego, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinomaJoan Maurel, Andrés Cervantes, Carlos Conill, et al.
Future Oncology (London, England)|July 14, 2017
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastasesEnrique Aranda, Jorge Aparicio, José Ignacio Bilbao, et al.
ESMO Open|October 13, 2017
Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patientsAnastassia Negrouk, Denis Lacombe, Fatima Cardoso, et al.
Seminars in Cancer Biology|September 26, 2025
Lipid-laden macrophages in atherosclerosis and cancerM C Martinez-Campanario, Marlies Cortés, Lu Han, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 3, 2023
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)Ana Fernández Montes, Vicente Alonso, Enrique Aranda, et al.
Molecular Carcinogenesis|February 4, 2015
LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-METBelén Mezquita, Estela Pineda, Jovita Mezquita, et al.
Journal of Pain and Symptom Management|August 30, 2008
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancerS Gail Eckhardt, Peter De Porre, David Smith, et al.
Pageof 12